Lazard Asset Management
FLGT icon

Lazard Asset Management’s Fulgent Genetics FLGT Stock Holding History

Lazard Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,785
Closed -$82K – 2364
2024
Q3 		$82K Buy
+3,785
New +$84.6K ﹤0.01% 1816
2023
Q1 		– Sell
-1,556
Closed -$46K – 2380
2022
Q4 		$46K Buy
+1,556
New +$55.7K ﹤0.01% 1856
2022
Q3 		– Sell
-862
Closed -$47K – 2396
2022
Q2 		$47K Hold
862
– – ﹤0.01% 1844
2022
Q1 		$53K Sell
862
-4,264
-83% -$281K ﹤0.01% 1709
2021
Q4 		$515K Buy
+5,126
New +$451K ﹤0.01% 1097

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management's FLGT Position: Q4 2024 in Review

Lazard Asset Management sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 3,785 shares — an estimated $82K sold.

Lazard Asset Management first reported a position in FLGT in Q4 2021 and held it in 5 quarters. The position peaked at $515K in Q4 2021. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Lazard Asset Management reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 3,785 Fulgent Genetics shares in Q4 2024, an estimated $82K.
  • Lazard Asset Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 5 quarters.
  • Lazard Asset Management's Fulgent Genetics position peaked at $515K in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.